Neuroone Medical Technologies Corp
NASDAQ:NMTC
Neuroone Medical Technologies Corp
Cash from Financing Activities
Neuroone Medical Technologies Corp
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Neuroone Medical Technologies Corp
NASDAQ:NMTC
|
Cash from Financing Activities
$8.6m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
83%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-425%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Neuroone Medical Technologies Corp's Cash from Financing Activities?
Cash from Financing Activities
8.6m
USD
Based on the financial report for Dec 31, 2023, Neuroone Medical Technologies Corp's Cash from Financing Activities amounts to 8.6m USD.
What is Neuroone Medical Technologies Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
83%
The average annual Cash from Financing Activities growth rates for Neuroone Medical Technologies Corp have been -2% over the past three years , 21% over the past five years , and 83% over the past ten years .